British scientists have developed a stem cell breakthrough that might free diabetics from painful daily dose of injections.
The new research conducted by London's Imperial College involves engineering blood stem cells into insulin-secreting cells, the Daily Express reported.
Researchers believe the new technique will make it possible to treat diabetic patients with an annual injection of insulin.
The lead author, Professor Nagy Habib, and scientists at Hammersmith Hospital are now planning human trials of the new treatment after success in laboratory studies.
Dr Paul Mintz, a leading stem cell researcher at Imperial College, who is part of the team pioneering the research, told the publication that the beauty of this treatment is that they manipulate the patient's own stem cells, avoiding the complication of giving them something foreign which their body will reject.
The researchers have been able to get 35 per cent of engineered cells to make insulin in laboratory studies, but they are now planning to grow these cells so that they have a colony of 100 per cent insulin-making cells that can be injected into a patient's body.
The study was published in Journal of Molecular Therapy Nucleic Acids last week.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
